Business
‘Robust immune responses’: Oxford virus trial offers hope for elderly – The New Daily
Oxford University-AstraZeneca’s coronavirus vaccine has produced a robust immune response in elderly people, according to early test results.
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca says.
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.
The Financial Times reported the vaccine, being developed by Oxford and AstraZeneca,…
-
Noosa News22 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General21 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General23 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News23 hours agoCrackdown on illegal e-bikes as police start fining parents for buying their children the deadly toys